Introduction
All you need to know about JUSLINE 30/70 100 U/ml .
Welcome to Dwaey, specifically on JUSLINE 30/70 100 U/ml page.
This medicine contains an important and useful components, as it consists of Insulin - Isophane biphasic (human) (Soluble/Regular 30%, Isophane 70%).
JUSLINE 30/70 100 U/ml is available in the market in concentration 100IU/ml and in the form of Injection.
JULPHAR (GULF PHARMACEUTICAL INDUSTRIES) is the producer of JUSLINE 30/70 100 U/ml and it is imported from UAE, The most popular alternatives of JUSLINE 30/70 100 U/ml are listed downward .
-
Active Substance
Insulin - Isophane biphasic (human) (Soluble/Regular 30%, Isophane 70%)
-
Size
10ml Vial
-
Indications
- No indications available.
-
Type
Injection
-
Company
JULPHAR (GULF PHARMACEUTICAL INDUSTRIES)
Frequently Asked Questions
JUSLINE 30/70 100 U/ml should be stored according to the instructions provided by JULPHAR (GULF PHARMACEUTICAL INDUSTRIES).
In general, it is recommended to store JUSLINE 30/70 100 U/ml in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with JUSLINE 30/70 100 U/ml may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking JUSLINE 30/70 100 U/ml for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking JUSLINE 30/70 100 U/ml. Some medications, including
JUSLINE 30/70 100 U/ml, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of JUSLINE 30/70 100 U/ml, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking JUSLINE 30/70 100 U/ml without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking JUSLINE 30/70 100 U/ml if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of JUSLINE 30/70 100 U/ml during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 100IU/ml,
and the specific recommendations of JULPHAR (GULF PHARMACEUTICAL INDUSTRIES).
The effects of JUSLINE 30/70 100 U/ml on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 100IU/ml, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking JUSLINE 30/70 100 U/ml with or without food may vary depending on the medication
and the recommendations of JULPHAR (GULF PHARMACEUTICAL INDUSTRIES). Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of JUSLINE 30/70 100 U/ml in children or elderly individuals may depend on various factors, including
the specific medication, type Injection, and the recommendations of JULPHAR (GULF PHARMACEUTICAL INDUSTRIES). Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of JUSLINE 30/70 100 U/ml in children or elderly individuals.
0 Comments